Treatment for women with a specific type of PCOS
Official title: Treatment of Menstrual Cycle Alterations in Women with PCOS of Phenotype D Using Dietary Supplementation That Combines Diosgenin, Vitamin D and Alpha-lactalbumin
Run by Lo.Li.Pharma s.r.l · NCT06639698 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing a dietary supplement to see if it can help women with a specific type of PCOS get their menstrual cycles back on track and improve their ovarian health.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 20 (estimated) |
| Sponsor | Lo.Li.Pharma s.r.l Industry-sponsored |
| Locations | 1 site (Rome, ITA) |
| Trial ID | NCT06639698 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are women diagnosed with PCOS of phenotype D who meet the inclusion criteria.
✕Probably not a fit
Patients with other phenotypes of PCOS, hormonal treatments, or significant metabolic alterations may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial focuses on female patients diagnosed with PCOS of phenotype D, characterized by menstrual cycle alterations and normal androgen levels. Participants will receive a dietary supplement containing Dioscorea extract, vitamin D, and alpha-lactalbumin for six months. The primary goal is to restore regular menstrual cycles and improve the ultrasound appearance of the ovaries, addressing the limitations of current treatments for this phenotype. The study aims to evaluate the efficacy of this natural approach in managing symptoms of PCOS phenotype D.
Why it matters
Potential benefit: If successful, this treatment could provide a new, effective option for managing symptoms of PCOS phenotype D without the side effects of traditional hormonal therapies.
How similar studies have gone: While there is limited data on the specific use of Diosgenin for this phenotype, other studies exploring natural supplements for PCOS have shown promising results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of PCOS of phenotype D, according to the Rotterdam Criteria and the EGOI-PCOS Criteria Exclusion Criteria: * Diagnosis of PCOS of phenotype A, B or C, according to the Rotterdam Criteria and the EGOI-PCOS Criteria * Hormonal treatments; * Treatments with inositol or other insulin sensitizers (such as metformin); * Insulin resistance or pre-diabetes condition * BMI \> 30 * Endocrinological alterations * Chronic pharmacological therapies * Major pathological conditions (e.g. tumors or autoimmune diseases)
Where it's running
-
Alma Res Fertility Center
Rome, Ita, Italy Recruiting
Study contacts
- Study coordinator: Cesare Aragona
- Email: aragonacesare@gmail.com
- Phone: +39 348 4043527
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ovarian drilling via vNOTES laparoscopy for PCOS patients
This study tests whether drilling the ovaries using vNOTES laparoscopy can help women with PCOS who did not respond to first-line medicines.
-
PMOS and Sleep Apnea: A Pilot Look at Mitochondrial Function
In women with PMOS, this pilot study tests whether sleep apnea treatment with CPAP improves mitochondrial function in leg muscle tissue.
-
Lean Beef as Part of a Healthy Meal Plan for Adolescent Girls with PCOS/PMOS
This pilot study tests a lean beef–based meal plan to see if it improves blood sugar control and diet quality in adolescent girls with PCOS/PMOS.
-
Inositol and Metformin with Mediterranean or Low-Carb Diets in Women with PCOS
This trial tests whether adding inositol, metformin, or folic acid to either a Mediterranean or a low-carbohydrate diet helps women with PCOS and insulin resistance lose weight and improve metabolic markers.
-
Fecal microbiota transplantation for overweight women with PMOS undergoing embryo transfer
We are testing if oral FMT capsules are safe and can improve pregnancy outcomes for overweight/obese women with PMOS undergoing frozen embryo transfer.
-
Glp-1/FGF21 dual agonist for PCOS treatment
This study tests a GLP-1/FGF21 dual agonist to see if it helps women with PCOS by improving weight, hormones, and menstrual health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.